![Hans-Peter Gerber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Peter Gerber
Directeur Technique/Scientifique/R&D chez
SUTRO BIOPHARMA, INC.
Fortune : 324 298 $ au 30/06/2026
Profil
Hans-Peter Gerber currently works at T-CURX GmbH, as Chairman and Sutro Biopharma, Inc., as Chief Scientific Officer from 2023.
Dr. Gerber also formerly worked at NBE-Therapeutics AG, as Independent Director from 2017 to 2021 and Maverick Therapeutics, Inc., as President, Director & Chief Science Officer from 2016 to 2018.
Dr. Gerber received his graduate degree and doctorate degree from the University of Zurich.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 9 768 ( 0,06% ) | 324 298 $ | 30/06/2026 |
Postes actifs de Hans-Peter Gerber
| Sociétés | Poste | Début |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 18/09/2023 |
T-CURX GmbH
 T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Président | - |
Anciens postes connus de Hans-Peter Gerber
| Sociétés | Poste | Fin |
|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Directeur/Membre du Conseil | 01/01/2021 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | President | 01/01/2018 |
Formation de Hans-Peter Gerber
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
T-CURX GmbH
T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Health Technology |
